Article

Nvidia and Eli Lilly are investing $1 billion over five years to establish a joint AI research lab in the San Francisco Bay Area, leveraging Nvidia's Vera Rubin AI chips to enhance drug development. This initiative, announced during the JPMorgan Healthcare Conference, aims to integrate advanced AI models into Eli Lilly's pharmaceutical processes, with the facility's location set to be revealed in March. Researchers from both companies will collaborate on generating data for AI model training in biotechnology.